SK바이오팜
75,800KRWMarket close of 10/26 (Mon)
Down -1.43%-1,100KRWMarket close of 10/26 (Mon)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/27 (Tue)74,900KRWDown -1.19%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 76,000
- High
- 77,900
- Low
- 75,250
- Day range
- Day range low 75,250 high 77,900, open 76,000, close 75,800, previous close 76,900
- Volume
- 14×10K shares
- 10.9B KRW 1.36× the 20-session average
Market close of 10/26 (Mon)
Where it sits in the 1-year range
9%1-year close range 69,400 to 140,700 won, 9% up from the low
9% of the way up from the lowest close in 1 year (252 sessions) · -46.1% from the high
Loading
Free · no sign-inSource from 2021-05-17
Data dateMost recent closing data10/26 (Mon)
Market close data of 2026-10-26Points to check
- Recent filingsnot verifiedCould not read filing data, so not verified
- Daily moveusual range-1.43%-1.43%, 0.8× the usual (20-session average ±1.73%)That day -1.43% · usual ±1.73% · large-move threshold ±3.5%
- Trading valueusual range1.4×10.9B KRW, 1.4× the 20-session average1.36× the 20-session average · check threshold 3×
The other 2 are within the usual range
- EarningsOperating income, 8 quarters
- Foreign & institutional+6.5B KRWusual range
See the full check report
Same sector · 바이오 R&D
Down -2.55%· 13 of 64 stocks up, preferred shares excluded · trading value 166.4B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 알테오젠 | Close over the last 20 sessions -12.4% | Down -2.67% | 36.1B KRW |
| 프로티나 | Close over the last 20 sessions +16.6% | Up +7.25% | 15.2B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -5.0% | Down -0.25% | 12.5B KRW |
| 올릭스 | Close over the last 20 sessions -6.0% | Down -6.97% | 10.3B KRW |
| 리가켐바이오 | Close over the last 20 sessions -19.1% | Down -4.84% | 9.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 19 days
- Next data 10/28 (Wed) after 08:50
Related news
Loading
Tables, financials, investor flows and filing history are in the Detailed view.
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.